SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.202
AS - Asia 26.776
EU - Europa 21.105
SA - Sud America 4.521
AF - Africa 602
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 2
Totale 105.305
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.305
SG - Singapore 10.303
FI - Finlandia 6.702
CN - Cina 6.553
IT - Italia 3.984
BR - Brasile 3.472
VN - Vietnam 2.736
UA - Ucraina 2.506
HK - Hong Kong 2.389
DE - Germania 2.164
TR - Turchia 1.621
GB - Regno Unito 1.468
FR - Francia 958
SE - Svezia 778
RU - Federazione Russa 726
PL - Polonia 662
JP - Giappone 625
IN - India 540
MX - Messico 409
CA - Canada 351
ID - Indonesia 351
AR - Argentina 348
BD - Bangladesh 338
IQ - Iraq 220
NL - Olanda 219
ZA - Sudafrica 197
EC - Ecuador 179
ES - Italia 169
CO - Colombia 166
PK - Pakistan 165
BE - Belgio 123
VE - Venezuela 114
AT - Austria 110
PH - Filippine 101
SA - Arabia Saudita 94
UZ - Uzbekistan 90
MY - Malesia 88
MA - Marocco 86
CL - Cile 77
CZ - Repubblica Ceca 70
LT - Lituania 70
IE - Irlanda 67
PY - Paraguay 66
EG - Egitto 64
AE - Emirati Arabi Uniti 58
AU - Australia 57
CH - Svizzera 55
TN - Tunisia 55
KE - Kenya 53
KR - Corea 50
JO - Giordania 42
PE - Perù 41
TH - Thailandia 32
UY - Uruguay 32
IL - Israele 29
OM - Oman 29
AL - Albania 28
DZ - Algeria 27
KZ - Kazakistan 27
RO - Romania 27
TW - Taiwan 27
JM - Giamaica 26
ET - Etiopia 25
IR - Iran 24
AZ - Azerbaigian 22
LK - Sri Lanka 22
NP - Nepal 22
SN - Senegal 22
BG - Bulgaria 21
LB - Libano 21
RS - Serbia 21
GE - Georgia 20
GR - Grecia 20
CR - Costa Rica 19
HU - Ungheria 19
PT - Portogallo 19
HR - Croazia 18
KG - Kirghizistan 18
PS - Palestinian Territory 18
BO - Bolivia 16
NO - Norvegia 16
NZ - Nuova Zelanda 15
BH - Bahrain 13
DO - Repubblica Dominicana 13
KW - Kuwait 13
EU - Europa 12
PA - Panama 12
TT - Trinidad e Tobago 12
AM - Armenia 10
BA - Bosnia-Erzegovina 10
CI - Costa d'Avorio 10
GT - Guatemala 10
HN - Honduras 10
MD - Moldavia 10
NI - Nicaragua 10
SY - Repubblica araba siriana 10
XK - ???statistics.table.value.countryCode.XK??? 10
BY - Bielorussia 9
DK - Danimarca 9
LY - Libia 9
Totale 105.109
Salva come PNG Salva come JPEG
Città #
Singapore 6.384
Helsinki 6.052
Ashburn 5.636
Fairfield 5.338
Woodbridge 5.001
Houston 3.196
Jacksonville 2.711
Chandler 2.390
San Jose 2.370
Hong Kong 2.343
Seattle 2.127
Ann Arbor 2.106
Wilmington 1.878
Cambridge 1.776
Santa Clara 1.775
Beijing 1.766
Dallas 1.676
Izmir 960
Ho Chi Minh City 895
Nanjing 872
Princeton 751
Warsaw 622
Hanoi 613
Los Angeles 605
Tokyo 587
New York 586
Lauterbourg 550
San Diego 478
Boardman 462
Munich 431
Ferrara 412
Milan 389
Council Bluffs 341
São Paulo 325
Shanghai 288
Shenyang 264
Mexico City 263
Nanchang 245
Jakarta 234
Moscow 219
London 205
Rome 201
Chicago 195
Hefei 169
Tianjin 169
Changsha 156
Falls Church 155
Orem 149
Hebei 147
Jiaxing 147
Turku 139
Bremen 136
Redwood City 132
Buffalo 123
San Mateo 122
Rio de Janeiro 121
Mountain View 119
Dong Ket 118
Bologna 117
The Dalles 116
Brussels 115
Brooklyn 113
Montreal 111
Chennai 110
Addison 107
Frankfurt am Main 107
Da Nang 104
Haiphong 103
Johannesburg 103
Jinan 101
Nuremberg 93
Zhengzhou 93
Phoenix 85
Tashkent 85
Norwalk 82
Stockholm 82
Baghdad 80
Dearborn 80
Guangzhou 79
San Francisco 79
Atlanta 78
Falkenstein 75
Toronto 75
Naples 74
Manchester 73
Verona 71
Denver 70
Boston 69
Columbus 69
Belo Horizonte 67
Washington 66
Ningbo 65
Quito 65
Amsterdam 64
Kunming 63
Curitiba 60
Mumbai 58
Philadelphia 57
Brasília 56
Des Moines 56
Totale 72.096
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 2.938
17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells 2.135
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.051
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.832
Il lungo cammino degli inibitori dell'enzima di conversione dell'angiotensina nella lotta per le malattie cardiovascolari 518
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 427
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 416
Valutazione ecocardiografica dell'insufficienza mitralica nella prospettiva della riparazione valvolare 392
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 379
Left ventricular ejection fraction and heart failure: an indissoluble marriage? 372
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 368
The Notch pathway: a novel therapeutic target for cardiovascular diseases? 365
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 356
Scompenso cardiaco con frazione di eiezione intermedia. Alla ricerca della Terra di Mezzo? 330
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 314
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 306
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis 304
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study 300
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease 298
Poor response to clopidogrel: current and future options for its management 277
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 275
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) 274
Cardiac resynchronization therapy guided by multimodality cardiac imaging 273
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain 266
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 264
CANCER THERAPY-INDUCED CARDIOTOXICITY: ROLE OF ULTRASOUND DEFORMATION IMAGING AS AN AID TO EARLY DIAGNOSIS 264
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 260
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 259
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 258
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions 256
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 254
The role of Notch pathway in cardiovascular diseases. 253
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study 250
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 250
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 249
2013 ESH/ESC Guidelines for the management of arterial hypertension 248
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 248
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 246
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 242
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 241
Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain 241
2013 ESC guidelines on the management of stable coronary artery disease 240
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 239
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 237
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 237
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 236
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 236
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 234
Aortic valve stenosis and mitochondrial dysfunctions: Clinical and molecular perspectives 234
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 234
KRIT1 deficiency promotes aortic endothelial dysfunction 232
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 231
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 230
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 229
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 227
Attualità e nuove prospettive in tema di cardiogenetica 227
Reperfusion Damage - A Story of Success, Failure, and Hope 226
Uric acid and coronary artery disease: An elusive link deserving further attention 224
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 224
Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy 224
Current views on anthracycline cardiotoxicity 223
Heart failure with preserved ejection fraction: uncertainties and dilemmas 222
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 219
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 219
Anti-anginal drugs: Systematic review and clinical implications 217
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 216
2013 ESH/ESC Guidelines for the management of arterial hypertension 216
Angina and left ventricular dysfunction: can we "reduce' it? 214
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 213
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 213
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 212
181 QUESTIONS & ANSWERS IN HEART FAILURE Heart failure 181 Questions & Answers. 212
Current role of echocardiography in cardiac resynchronization therapy 211
Can we improve myocardial protection during ischaemic injury? 211
Efficacy and safety of catheter ablation of atrioventricular nodal re-entrant tachycardia by means of flexible-tip irrigated catheters 211
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 210
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion 206
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 206
null 206
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors 204
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 204
99mTc-sestamibi gted -Spect evaluation of post stress left ventricular ejection fraction and volumes in hypertensive patients exhibiting a normal scintigraphic perfusion pattern 203
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study 203
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 203
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 203
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 203
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 202
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 202
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 201
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry 201
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry 201
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 200
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 200
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 199
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 199
Remote monitoring of implantable devices: Should we continue to ignore it? 199
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 199
Prognosis after pacemaker implantation in extreme elderly 199
From left ventricular ejection fraction to cardiac hemodynamics: role of echocardiography in evaluating patients with heart failure 199
Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology 198
Totale 32.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 445.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.086
Totale 451.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.480 0 0 0 0 0 0 0 0 0 0 996 484
2021/20227.070 323 777 577 273 413 357 359 366 296 505 753 2.071
2022/20236.078 715 190 226 668 982 900 219 634 840 60 397 247
2023/20243.481 359 433 210 120 238 490 152 206 77 160 153 883
2024/202512.621 303 307 1.107 466 1.429 1.036 462 840 2.357 1.378 1.541 1.395
2025/202639.942 3.125 1.753 4.140 4.576 4.727 2.266 3.572 2.131 9.331 4.023 298 0
Totale 106.297